Headache, arthralgia, nasopharyngitis,upper respiratory infection, diarrhea and dizziness werereported. Caution recommended in patients with concomitant useof drugs that affect CYP2D6 and/or CYP3A substratemetabolism. The gene discussed is CYP3A4; the disease is nasopharyngitis.